These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10917238)

  • 1. Antimicrobial-resistant enterococcal isolates from fluoroquinolone-naive children.
    McNeeley DF; Eckert SJ; Noel GJ
    Pediatr Infect Dis J; 2000 Jul; 19(7):675-6. PubMed ID: 10917238
    [No Abstract]   [Full Text] [Related]  

  • 2. [Enterococci as uropathogens. Frequency of isolation and sensitivity to antibacterial agents].
    Guirguitzova B; Chankova D; Zozikov B; Minkov N
    Ann Urol (Paris); 1998; 32(1):15-9. PubMed ID: 9559070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibilities of clinical isolates of vancomycin-resistant enterococci.
    Evans PA; Norden CW; Rhoads S; Deobaldia J; Silber JL
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1406. PubMed ID: 9174211
    [No Abstract]   [Full Text] [Related]  

  • 4. Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacin.
    Bonilla HF; Zarins LT; Bradley SF; Kauffman CA
    Diagn Microbiol Infect Dis; 1996 Sep; 26(1):17-21. PubMed ID: 8950524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci.
    Itokazu GS; Nathan C; Hariharan R; Kostman JR; Kabins SA; Weinstein RA
    Chemotherapy; 1996; 42(4):235-9. PubMed ID: 8804789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of trovafloxacin (with or without ampicillin-sulbactam) against enterococci in an in vitro dynamic model of infection.
    Zinner SH; Gilbert D; Dudley MN
    Antimicrob Agents Chemother; 1998 Jan; 42(1):72-7. PubMed ID: 9449263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics.
    Elsner HA; Sobottka I; Feucht HH; Claussen M; Kaulfers PM; Laufs R; Mack D
    Chemotherapy; 2000; 46(2):104-10. PubMed ID: 10671760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin.
    Sánchez-Silos RM; Pérez-Giraldo C; Blanco MT; Morán FJ; Hurtado C; Gómez-García AC
    Chemotherapy; 2001 Dec; 47(6):415-20. PubMed ID: 11786656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in-vitro activity of LY333328, a new glycopeptide, against clinical isolates of vancomycin-resistant enterococci.
    Kirk M; Hill RL; Casewell MW; Beighton D
    Adv Exp Med Biol; 1997; 418():483-5. PubMed ID: 9331699
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.
    Weinstein MP
    J Clin Microbiol; 2001 Jul; 39(7):2729-31. PubMed ID: 11427608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of antimicrobial resistance and quinolone resistance factors in high-level ciprofloxacin-resistant Enterococcus faecalis and Enterococcus faecium isolates obtained from fresh produce and fecal samples of patients.
    Kim MC; Woo GJ
    J Sci Food Agric; 2017 Jul; 97(9):2858-2864. PubMed ID: 27790716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic resistant fecal isolates of Enterococci among unselected patients outside the clinical sector: an epidemiological study from Southern Germany.
    Lietzau S; Hoewner M; von Baum H; Marre R; Brenner H
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):275-7. PubMed ID: 16287198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility patterns of enterococci causing infections.
    Oncu S; Punar M; Eraksoy H
    Tohoku J Exp Med; 2004 Jan; 202(1):23-9. PubMed ID: 14738321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of the combination of trovafloxacin and other antibiotics against enterococci.
    Schick DG; Canawati HN; Montgomerie JZ
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):233-9. PubMed ID: 9458980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid increase in the prevalence of antimicrobial drug resistance among enterococcal blood isolates in southern Israel.
    Marcus N; Peled N; Yagupsky P
    Eur J Clin Microbiol Infect Dis; 1997 Dec; 16(12):913-5. PubMed ID: 9495672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Typing of Enterococcus spp. strains in 4 hospitals in the Małopolska region in Poland.
    Talaga K; Odrowąż-Konduracka D; Paradowska B; Jagiencarz-Starzec B; Wolak Z; Bulanda M; Szczypta A
    Adv Clin Exp Med; 2018 Jan; 27(1):111-117. PubMed ID: 29521051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children.
    Aamodt H; Mohn SC; Maselle S; Manji KP; Willems R; Jureen R; Langeland N; Blomberg B
    BMC Infect Dis; 2015 Feb; 15():107. PubMed ID: 25884316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of Enterococcus faecalis and Enterococcus faecium in Various Clinical Infections: Detection of Their Drug Resistance and Virulence Determinants.
    Jahansepas A; Aghazadeh M; Rezaee MA; Hasani A; Sharifi Y; Aghazadeh T; Mardaneh J
    Microb Drug Resist; 2018; 24(1):76-82. PubMed ID: 28525287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Australian Enterococcal Sepsis Outcome Programme annual report, 2013.
    Coombs GW; Pearson JC; Daly DA; Le TT; Robinson JO; Gottlieb T; Howden BP; Johnson PD; Bennett CM; Stinear TP; Turnidge JD;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E320-6. PubMed ID: 25631594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group.
    Schouten MA; Voss A; Hoogkamp-Korstanje JA
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2542-6. PubMed ID: 10508041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.